AZoM on MSN5h
Harnessing Quantum Computing for the Design of Advanced Photochromic Materials
The integration of quantum chemistry and machine learning in this study accelerates the discovery of photochromic materials, ...
Precise binding free energy calculations unlock new frontiers in drug design
Drug discovery is a costly and time-intensive process, with binding free energy calculations between the potential drug ...
BioSpace6d
FDA Approves Vertex’s Journavx as First New Pain Drug in Decades
The greenlight for Journavx (suzetrigine), which comes on the heels of a $7.4 billion opioid settlement, could spark momentum ...
Novel quantum-classical computing scheme for designing light-sensitive compounds could accelerate material discovery
Recently, a joint research team developed a novel quantum-classical computing scheme for designing photochromic ...
USA Today6d
FDA approves new pain medication as an alternative to opioids: What to know about Journavx
For the first time in two decades, the Food and Drug Administration (FDA) has approved a new class of medication that provides an alternative to addictive opioids for patients looking to manage ...
U.S. FDA approves Supernus' drug-device combination for Parkinson's disease
The U.S. Food and Drug Administration has approved Supernus Pharmaceuticals' drug-device combination to treat movement-related symptoms of Parkinson's disease, the drugmaker said on Tuesday.
COUR Pharmaceuticals Secures FDA Clearance of IND Application for CNP-103 in Type 1 Diabetes
The Phase 1b/2a study will assess the safety of CNP-103 in adults (aged 18-35) and pediatrics (aged 12-17) who have Stage III or newly diagnosed (within the last 6 months) T1D as well as C-peptide ...
Medscape6d
Introduction to the New Prescription Drug Labeling by the Food and Drug Administration
The revision of labeling for products approved or submitted for approval under an abbreviated new drug application (ANDA) depends on the labeling of the listed drug referenced in the ANDA.
Everyday Health6d
FDA Approves First New Type of Pain Medication in More Than 20 Years
It’s the first drug in a new family of medicines that block pain signals before they reach the brain. Suzetrigine is a nonaddictive alternative to opioids for pain relief. The U.S. Food and Drug ...
eLife2d
Drug combination prediction for cancer treatment using disease-specific drug response profiles and single-cell transcriptional signatures
retriever generates disease-specific transcriptional drug response signatures by merging transcriptional signatures over time, concentration, and cell-type. These signatures can then be matched to ...
JD Supra6d
Rethinking FDA’s Accelerated Approval Pathway: New Draft Guidances and Implications for Drug Companies
The U.S. Food and Drug Administration (FDA) recently issued two new guidance documents governing details of the Accelerated Approval ...